Investigating the Inhibitory Properties of Diazo and Pyrazole‐Carboxamide‐Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII
ChemMedChem · 2026-07-14 · 21 (13)
DOI: 10.1002/cmdc.70369 ↗At a glance
Journal article in ChemMedChem, published online on 2026-07-06. Written by Suleyman Akocak and 8 co-authors. Institution: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Adıyaman University, Adıyaman, Türkiye. Major MEDLINE topics: Carbonic Anhydrase Inhibitors, Sulfonamides, Pyrazoles, Carbonic Anhydrases. Cited 2 times so far (Crossref); 71 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.
Abstract (original language)
A novel library of diazo and pyrazole‐carboxamide‐linked molecules containing the sulfonamide pharmacophore was developed and synthesized, yielding selective inhibitors of clinically relevant carbonic anhydrase (CA) isoforms. The synthesis method involved the production of diazonium salts from 4‐ and 3‐aminobenzenesulfonamide precursors, followed by cyclization and further functionalization to yield structurally diverse pyrazole derivatives. All compounds were evaluated for their inhibitory efficacy against hCA I and II (cytosolic isoforms) and the tumor‐associated isoenzymes hCA IX and XII; also, cytotoxicity and molecular modeling studies were conducted for the compounds. The newly synthesized hybrid compounds displayed extensive inhibitory activity, with most derivatives showing significant potency and selectivity for cancer‐associated isoforms. More specifically, para‐substituted analogs exhibited enhanced inhibitory properties relative to their meta‐substituted counterparts. Compound 5f , with a 3,4‐dichloro motif, exhibited the highest activity with a very low K I value of 1.8 nM against hCA IX, greatly surpassing the reference drug acetazolamide. Electron‐withdrawing substituents improved inhibitory efficacy, whereas electron‐donating groups often reduced activity. Furthermore, compounds 5f (A549: 41.17 μM; HCT116: 4.47 μM) and 6c (A549: 14.64 μM; HCT116: 4.03 μM) showed the lowest IC 50 values in both cell lines. The findings emphasize diazo‐ and pyrazole‐carboxamide‐linked benzenesulfonamides as promising scaffolds for advancing isoform‐selective carbonic anhydrase inhibitors.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Adıyaman University, Adıyaman, Türkiye.
- Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Florence, Italy.
- Faculty of Pharmacy, Adıyaman University, Adıyaman, Türkiye.
- Department of Medical Biology, Faculty of Medicine, Adıyaman University, Adıyaman, Türkiye.
- Department of Medical Biochemistry, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University, Sohag, Egypt.
ORCID profiles: Suleyman Akocak, Nebih Lolak, Claudiu T Supuran
Funding
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Cite
APA
Akocak, S., Lolak, N., Ammara, A., Gürbüz, G., Bozgeyik, I., Taşdemir, D., Hashem, H., Bräse, S., & Supuran, C. T. (2026). Investigating the Inhibitory Properties of Diazo and Pyrazole‐Carboxamide‐Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII. ChemMedChem, 21(13). https://doi.org/10.1002/cmdc.70369
Vancouver
Akocak S, Lolak N, Ammara A, Gürbüz G, Bozgeyik I, Taşdemir D, et al. Investigating the Inhibitory Properties of Diazo and Pyrazole‐Carboxamide‐Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII. ChemMedChem. 2026;21(13). doi:10.1002/cmdc.70369
BibTeX
@article{Akocak2026,
author = {Akocak, Suleyman and Lolak, Nebih and Ammara, Andrea and Gürbüz, Gökçenur and Bozgeyik, Ibrahim and Taşdemir, Demet and Hashem, Hamada and Bräse, Stefan and Supuran, Claudiu T},
title = {Investigating the Inhibitory Properties of Diazo and Pyrazole‐Carboxamide‐Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {13},
doi = {10.1002/cmdc.70369}
}
EUVIMED